ENDOMETRIAL CARCINOMA
Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can weight loss boost hormone therapy for Fertility-Sparing endometrial cancer treatment?
Disease control TerminatedThis study looked at whether adding weight management to a hormone drug (megestrol acetate) helps obese patients with early-stage endometrial cancer who want to preserve fertility. Only 8 people enrolled before the study ended early. The goal was to see if the cancer would disapp…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Xiaojun Chen • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Cancer drug combo trial ends early after only 9 patients
Disease control TerminatedThis study tested a combination of two drugs, futibatinib and pembrolizumab, in people with a hard-to-treat type of advanced endometrial cancer called microsatellite stable (MSS). The goal was to see if the combo could shrink tumors or slow the cancer. The trial was stopped early…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC